MELBOURNE, Australia, Jan. 7, 2014 /PRNewswire/ — Australian women will potentially have greater access to the only genomic test validated to predict whether patients with early-stage invasive breast cancer would benefit from chemotherapy, following …
http://ifttt.com/images/no_image_card.png
0 comments:
Post a Comment